Total Funding
43
49
Total FundingPost-IPO Equity raised
Growth Score
-32 pts
Heat Score
-5 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
72578
Pila Pharma is a TRPV1-platform focused company developing oral treatments for type-2 diabetes, obesity, and pain.
- Dorte X. Gram: CEO
- Gustav Hanghøj Gram: Head of Investor Relations
About the Company
Pila Pharma is a clinical stage biotech company developing a potent, selective TRPV1 antagonist, XEN-D0501, as treatment of type 2 diabetes, obesity, and the rare painful disease erythromelalgia.
